| Autor: |
Levin D; Department of Anesthesiology, Perioperative Care & Pain Medicine, New York University Langone Health, New York, NY 10016, USA., Van Florcke D; Department of Anesthesiology, Perioperative Care & Pain Medicine, New York University Langone Health, New York, NY 10016, USA., Schmitt M; Department of Physical Medicine and Rehabilitation, New York University Langone Health, New York, NY 10016, USA., Kendall LK; Department of Physical Medicine and Rehabilitation, New York University Langone Health, New York, NY 10016, USA., Patel A; Department of Anesthesiology, Critical Care & Pain Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA., Doan LV; Department of Anesthesiology, Perioperative Care & Pain Medicine, New York University Langone Health, New York, NY 10016, USA., Kirpekar M; Department of Anesthesiology, Perioperative Care & Pain Medicine, New York University Langone Health, New York, NY 10016, USA. |
| Abstrakt: |
Background/Objective: Pudendal neuralgia is a distressing condition that presents with pain in the perineum. While a positive anesthetic pudendal nerve block is one of the essential criteria for diagnosing this condition, this block can also provide a therapeutic effect for those afflicted with pudendal neuralgia. There are multiple ways in which a pudendal nerve block can be performed. The objective of this study is to share our results and follow-up of fluoroscopy-guided transgluteal pudendal nerve blocks. Methods: This is a retrospective case series. Included were 101 patients who met four out of the five Nantes criteria (pain in the anatomical territory of the pudendal nerve, pain worsened by sitting, pain that does not wake the patient up at night, and no objective sensory loss on clinical examination) who did not respond to conservative treatment and subsequently underwent a fluoroscopy-guided transgluteal pudendal nerve block. Therapeutic success was defined as a 30% or greater reduction in pain. Success rates were calculated, and the duration over which that success was sustained was recorded. Results: For achieving at least 30% relief of pain, using worst-case analysis, the success rate at two weeks was 49.4% (95% CI: 38.5%, 60.3%). In addition to pain relief, patients experienced other therapeutic benefits, such as reductions in medication use and improvements in activities of daily living. Conclusions: Fluoroscopy-guided transgluteal pudendal nerve block appears to be effective in patients who have pudendal neuralgia that is resistant to conservative therapy, with good short-term success. |
